Edwin Van Vulpen
Edwin van Vulpen joined QPS in August 2010 as Senior Director of Business Development. He is presently responsible for client services in the early phase clinical services area. Edwin joined the CRO business in 1998 when he started working for Harlan Sprague Dawley followed by Citeq Biologics and Xendo Drug Development where he worked for three years. He has excellent capabilities in leading complex business development opportunities through the closing phase together with his client. He also headed some influential marketing campaigns to increase awareness of range of services in several companies. Edwin has a B.A. background from the Nyenrode Business University.